Ovid Therapeutics (OVID) EBT Margin (2020 - 2026)
Ovid Therapeutics (OVID) recorded EBT Margin of -2047.61% in Q2 2026, down 1972.93 percentage points from -74.68% a year earlier.
Powered by 
Analysis
Ovid Therapeutics (OVID) EBT Margin (2020 - 2026) Analysis & Trends
On a TTM basis, Ovid Therapeutics' EBT Margin came in at -2178.90% as of Jun 30, 2026, down 1604.88 percentage points year-over-year; for FY2025, it came in at -240.13%, up 4430.01 percentage points from FY2024.
- Annual EBT Margin has a five-year change of +402.13 percentage points (FY2020 to FY2025).
- Across earlier years, EBT Margin came in at -4670.14% in FY2024 (+8681.64 pp), -13351.79% in FY2023 (-9747.12 pp), -3604.66% in FY2022 (-3664.25 pp) and 59.58% in FY2021 (+701.85 pp).
- Quarterly EBT Margin has ranged from -107798.33% in Q3 2022 to 5042.01% in Q2 2024 over the past five years.
- On a year-over-year basis, EBT Margin rose in three of the last seven quarters, with an average year-over-year change of +883.98 percentage points.
- Peak year-over-year performance for EBT Margin in the last five years was a gain of 97474.48 percentage points in Q3 2023, against a drop of 19125.36 percentage points in Q1 2023 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 26.66% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 25.18% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -4.11% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 29.63% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 18.19% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 27.53% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -131.41% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -4.34% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 41.75% |
| 10 | Ovid Therapeutics | 454.50 Mn | 86.52 Mn | - | -2,047.61% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2,047.61% |
| Dec 31, 2025 | 1,345.82% |
| Sep 30, 2025 | -9,210.61% |
| Jun 30, 2025 | -74.68% |
| Mar 31, 2025 | -7,873.08% |
| Dec 31, 2024 | -12,175.00% |
| Sep 30, 2024 | -8,095.95% |
| Jun 30, 2024 | 5,042.01% |
| Mar 31, 2024 | -7,901.35% |
| Dec 31, 2023 | -10,790.14% |
| Sep 30, 2023 | -10,323.85% |
| Jun 30, 2023 | -16,544.00% |
| Mar 31, 2023 | -20,236.36% |
| Dec 31, 2022 | -24,859.09% |
| Sep 30, 2022 | -107,798.33% |
| Mar 31, 2022 | -1,111.00% |
| Mar 31, 2021 | 84.70% |
| Dec 31, 2020 | -386.27% |
| Sep 30, 2020 | -237.56% |
API Access
Ovid Therapeutics EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=OVID&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "OVID", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=OVID&period=max&api_key=YOUR_API_KEY");
const data = await res.json();